News

Kurin, Inc. Announces Hire of EVP Operations Amid Record Growth

January 22, 2020

Kurin, Inc. Reports Record Third Quarter Revenues

October 2, 2019

Kurin, Inc. receives CE Mark for its novel Kurin Lock®

May 21, 2019

Kurin Inc. Responds to Allegations Published by Magnolia Medical Regarding Patent Infringement

March 14, 2019

Kurin, Inc. CEO Addresses Patent Infringement Lawsuit Brought by Magnolia Medical

February 12, 2019

Kurin, Inc. receives FDA 510k clearance for its novel Kurin Lock with peripheral IV infusion set.

January 30, 2019

Kurin, Inc. announces clinical results on Kurin® efficacy from Central Texas Veterans Health Care System

October 16, 2018

Kurin, Inc. Announces Agreement with Premier for Kurin Lock® to help impact contaminated blood cultures

October 2, 2018

Kurin, Inc. Announces Educational Website on the Importance of Improving Value of the Blood Culture Test

September 18, 2018

Clinical results of Kurin specimen diversion technology signal a shift in the blood culture collection standard of care.

August 31, 2018

Kurin CEO responds to Magnolia Medical Countersuit Press Release

August 17, 2018

Kurin, Inc. Receives Allowance from United States Patent and Trademark Office for Patent on Innovative Blood Culture Collection Device

July 17, 2018

Kurin, Inc. announces clinical study results of the Kurin Lock™ blood culture initial specimen diversion device at the APIC Annual Conference.

June 13, 2018

Kurin, Inc. sues Magnolia Medical for misleading consumers about FDA clearance and efficacy

May 31, 2018

Kurin, Inc. Receives Allowance from United States Patent and Trademark Office for Patent on Innovative Blood Culture Collection Device

November 28, 2017

ML-021 Rev A